The Anmat Authorized the over-the-Counter Sale of Ten Prescription-only Medicines
12 Articles
12 Articles
The measure reaches oral, ophthalmic and topical administration products that have been on the market for at least five years without reports of serious adverse effects that alter their balance between risks and benefits
The decision of the Anmat reaches active principles used to treat allergies, digestive disorders, dizziness, colds, dermatological conditions and other diseases of low complexity. The Government maintains that the decision seeks to expand access and favor a decrease in prices. They add to a long list of remedies that are no longer sold under prescription.
The measure seeks to facilitate access to medicines of proven safety, quality and efficacy, while promoting their responsible use.
The National Administration of Medications, Food and Medical Technology (ANMAT) expanded the list of medicines that can be sold without a medical prescription. The measure was officialized by Regulation 4714/2026, published in the Official Gazette, with the aim of facilitating access to treatments for mild pathologies and encouraging responsible use of these products. The regulation states that the change of supply condition reaches only those m…
The National Administration of Medications, Food and Medical Technology (ANMAT) established the condition of over-the-counter sale for ten groups of medicines that until now can only be purchased with a medical prescription. The decision was officialized through Regulation 4714/2026, published on Tuesday, July 28, in the Official Gazette. According to the ANMAT, the measure reaches all medicinal specialties registered in the Registry of Medicina…
The National Administration of Medications, Food and Medical Technology (ANMAT) established that ten groups of medicines that could only be purchased with a medical prescription are over-the-counter. This implies that, from now on, they can no longer be purchased at a discount in pharmacies. The list includes remedies for digestive problems, antihistamines and ophthalmological products. According to Regulation 4714/2026 published on Tuesday, it …
Coverage Details
Bias Distribution
- 100% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
